News

San Antonio biotech acquires U.K. wound-care company

Acelity LP President and CEO Andrew Eckert says the company's acquisition of England's Crawford Healthcare ...

Kiromic founder says Houston biotech’s move to SA nearly a done deal

Houston-based immunotherapy company Kiromic is expected this month to approve moving its headquarters ...

Events

4th Annual SURF 2018

What: San Antonio Military Health System and Universities ResearchForum When: Thursday, June ...

SwRI 2018 International Human Performance Summit

June 30-July 1, 2018 The Summit will be hosted by Southwest Research Institute as part of its ongoing ...
Healthcare & Bioscience Industry Action Plan: Doing Well by Doing Good


Leveraging San Antonio’s Unique Biomedical Assets to Fuel Economic Growth and Become a Resource to the World

The BioMed SA Industry Action Plan identifies tactical recommendations to support the creation of bioscience jobs, start-ups and continued investment in the San Antonio region as part of the community’s overall strategic plan for economic development, known as Forefront SA.

The recommendations are intended to help the community:
1) attract and recruit new businesses
2) retain and grow local businesses
3) ignite and nurture the entrepreneurial developments of startups

Phase One focuses on two areas in which San Antonio is particularly well-equipped to develop sector leadership: Diabetes and Infectious Disease.

The initial plan - previewed at BioMed SA's Annual Breakfast Meeting on December 13, 2017 - was developed through interviews with more than 80 local, regional, and national industry leaders, disease experts, and economic development professionals.

Execution of the plan’s recommendations will be a collaborative effort involving the entire San Antonio community, including public, private, academic, and government entities in the healthcare and bioscience sector.

The recommendations from this plan will take shape as industry leaders in the healthcare and bioscience sector come together to collaborate on the opportunities that could be implemented. BioMed SA expects to host a series of workshops with industry leaders to help shape tangible next steps for these recommended opportunities.

Phase Two of the Action Plan - to be developed and released in 2018 - will focus on Cancer, Neurological Disorders, as well as Trauma, Wound Healing and Regenerative Medicine.


Fill out my online form.
Stay informed. Subscribe to BioMed SA news alerts.